SIMONA AG O.N./ DE000A3E5CP0 /
2024-07-25 8:01:51 AM | Chg. 0.00 | Volume | Bid8:01:53 AM | Ask8:01:53 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
65.00EUR | 0.00% | 0 Turnover: 0.00 |
62.50Bid Size: 0 | 67.00Ask Size: 0 | 378 mill.EUR | 2.70% | 9.71 |
GlobeNewswire
06-24
Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results ...
GlobeNewswire
05-14
Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
GlobeNewswire
05-07
Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and ...
GlobeNewswire
05-02
Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
GlobeNewswire
04-30
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 F...
GlobeNewswire
04-23
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contrace...
GlobeNewswire
04-11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
03-28
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
GlobeNewswire
03-21
Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webc...
GlobeNewswire
02-23
Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging
GlobeNewswire
02-22
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISS...
GlobeNewswire
01-31
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cre...